NCT05553041 - 18F-Fluciclovine PET-MRI in High-grade Glioma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 7, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

GliomaHigh Grade GliomaGlioma, MalignantGlioma IntracranialDiffuse Glioma

Interventions

DRUG

18F-Fluciclovine PET-MRI

18F-Fluciclovine will be injected via IV prior to Positron emission tomography (PET)-Magnetic resonance imaging (MRI)

Trial Locations (1)

RECRUITING

Children's Hospital of Philadelphia, Philadelphia